Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Speeda Rabies Vaccine: Zagreb vs Essen Schedule
NCT01821911Phase 4Completed
- Sponsor
- Beijing Center for Disease Control and Prevention
- Start
- Jul 2012
- Primary completion
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of SPEEDA + TRCS SPEEDA in rabies, sponsored by Beijing Center for Disease Control and Prevention. Primary endpoint: Incidence Rate of Adverse Events at 2 years. Started Jul 2012; status: completed.
02
Drugs
SPEEDA + TRCS SPEEDA
03
Conditions
rabies
Beyond the preview
Go deeper on NCT01821911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821911.